| |
|
|
|
Infinity Pharmaceuti  
|
|
3.405 -0.015 (-0%) |
09-17 09:55 |
|
Open: |
3.45 |
Pre close: |
3.42 |
Target:
|
4.54
|
|
High: |
3.45 |
Low: |
3.375 |
Resistance:
|
3.89
4.54
|
|
Volume: |
299,136 |
Market Cap: |
302M |
Support:
|
3.19
2.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.42
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
3.45  |
Signal(12,26,9): |
0.17 |
|
MA(100): |
3.08 |
Stochastic Oscillator |
%K(14,3):
|
23.59 |
|
MA(250): |
2.72 |
%D(3): |
32.16 |
|
Average Volume(K) |
3-Month: |
14703037
|
52-Week |
High:
|
5.98 |
|
10-Days: |
5975676 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
52.35 |
Change(%): |
210.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.640 |
Return on Equity (ttm) |
-165.6 |
Shares Out. (M) |
88.65 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-29.2 |
Shares Float (M) |
71.76 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.17 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
9.1 |
% Held by Institutions |
55.96 |
|
Forward EPS |
-0.830 |
Gross Profit (p.s.) |
-0.294 |
Shares Short (K) |
3900 |
|
Book Value (p.s.) |
0.590 |
EBITDA (p.s.) |
-0.441 |
P/E |
-5.34 |
|
Sales Per Share |
0.020 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-37.43 |
P/S |
172.26 |
|
Operating Margin |
-2251.36 |
Levered Free Cash Flow
(M) |
-22.86 |
P/CF |
-8.10 |
|
|
|
|
|
|
